Empresa Willow Biosciences Inc Canadian Securities Exchange
Acciones
CA97111B1076
Farmacéuticos
Resumen de negocios
Ventas por actividad
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Research and Development
100,0
%
| 1 | 77,2 % | 1 | 100,0 % | +84,86 % |
Ventas por región
CAD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 77,2 % | 1 | 100,0 % | +84,86 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Chris Savile
CEO | Chief Executive Officer | - | 12/04/19 |
Travis Doupe
DFI | Director of Finance/CFO | - | 12/04/19 |
Trish Choudhary
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/19 |
Simon Hickling
PRN | Corporate Officer/Principal | - | - |
Sony Gill
SEC | Corporate Secretary | 48 | 12/04/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jim Lalonde
CHM | Chairman | 63 | 21/02/23 |
Donald Archibald
BRD | Director/Board Member | 63 | 12/04/19 |
Director/Board Member | 51 | 12/04/19 | |
Raffi Asadorian
BRD | Director/Board Member | 54 | 11/05/23 |
Chris Savile
CEO | Chief Executive Officer | - | 12/04/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 127 345 288 | 92 635 973 ( 72,74 %) | 0 | 72,74 % |
Información de la empresa
Willow Biosciences, Inc.
1201 5th Street South West Suite 202
T2R 0Y6, Calgary
+
http://www.willowbio.comVentas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,87 % | 93,91 mil M | |
-1,32 % | 38,4 mil M | |
-13,44 % | 32,61 mil M | |
+74,65 % | 28,2 mil M | |
-13,11 % | 15,91 mil M | |
+0,68 % | 14,22 mil M | |
-12,06 % | 11,54 mil M | |
+185,28 % | 10,74 mil M | |
-53,00 % | 9468,47 M |